1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Strategy

RB To Split OTC And Infant Nutrition As CEO Hits Reset Button

 
• By Tom Gallen

Reckitt Benckiser's new CEO Laxman Narasimhan has unveiled a turnaround plan which will see the company's OTC drugs and dietary supplements housed in a separate business to its infant nutrition products. RB is investing £2bn to get back on track after a couple of difficult years.

Hand man doing finances and calculate on desk about cost at home office.
• Source: Shutterstock

Reckitt Benckiser Group PLC’s Health business became “large, unwieldy and unfocused” under previous management, stated the firm’s new CEO Laxman Narasimhan.

Addressing investors as RB reported its 2019 results, Narasimhan – who took the helm on 1 September – was critical...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

Valbiotis Launches Plant-Based Heart Health Supplement

 
• By Tom Gallen

Available in French pharmacies and online, ValbiotisPRO Cardio-circulation comprises a blend of six plant extracts and is targeted at those with high blood pressure.

SkinBioTherapeutics Raises Funds For Supplement Development And Launch

 
• By Tom Gallen

UK-based firm will use the capital to launch its AxisBiotix skin health supplements in Superdrug stores and to develop new product formats.

Zentiva Strikes Deal With Aboca To Expand CHC Offering

 
• By Tom Gallen

Czech Republic's Zentiva snaps up Aboca portfolio adding supplement brands marketed in European countries such France, Italy and Spain.

US Consumer Health Sector Vigilant To Avoid Stumbling On Trump’s Tariff Twists And Turns

 
• By Malcolm Spicer

In remarks at recent investor conference reflecting comments from across the US consumer health sector, Kenvue chief Thibaut Mongon says, “I'm going to state the obvious. The environment is very fluid.”

More from Business

AESGP Annual Meeting: European OTC Market Outlook ‘Very Positive’ Thanks To Prevention Trend

 
• By David Ridley

The European OTC market grew at double the rate of the global market in the last twelve months, according to IQVIA Consumer Health, driven by a long-term trend for prevention. Consultancy Simon Kucher identifies a desire to live a longer, healthier life as the primary concern behind this trend.

Poland’s Formeds Acquired By Private Equity

 
• By Tom Gallen

Enterprise Investors takes 77% stake in Polish clean-label dietary supplements manufacturer Formeds.

BioGaia Takes Probiotics To Netherlands For First Time

 
• By Tom Gallen

Adopting an online approach, BioGaia is set to enter the Dutch market for probiotic dietary supplements. The firm announced the move as it reported lower sales in Q1.